This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Codiak Biosciences, Inc., Lonza Sales Ag. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Adam Thomas Boutin: Innovator in Macrophage Polarization
Introduction
Adam Thomas Boutin is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of 2 patents, Boutin is recognized for his work in macrophage polarization, which plays a crucial role in cancer therapy.
Latest Patents
Boutin's latest patent is titled "Methods and Compositions for Macrophage Polarization." This patent discloses compositions and methods that utilize extracellular vesicles containing nucleic acids to target specific genes. These methods lead to the polarization of tumor-associated macrophages, which is essential for enhancing the immune response against cancer. The disclosed methods aim to increase macrophage polarization, providing a potential therapeutic approach for cancer treatment.
Career Highlights
Throughout his career, Adam Thomas Boutin has worked with prominent companies in the biotechnology sector. He has been associated with Codiak Biosciences, Inc. and Lonza Sales Ag, where he has contributed to advancing research in his field. His expertise and innovative mindset have positioned him as a valuable asset in the industry.
Collaborations
Boutin has collaborated with notable professionals in his field, including Sushrut Kamerkar and Douglas E. Williams. These collaborations have further enriched his research and have contributed to the development of groundbreaking solutions in cancer treatment.
Conclusion
Adam Thomas Boutin is a distinguished inventor whose work in macrophage polarization has the potential to transform cancer therapy. His innovative patents and collaborations highlight his commitment to advancing medical science. His contributions are paving the way for new treatment options that could significantly impact patient outcomes.